Related Experiment Video
Updated: Jun 6, 2026
07:52
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Kidney disease in cardiology
1Cardiovascular Special Studies Center, United States Renal Data System, and Hennepin County Medical Center, University of Minnesota, Minneapolis, MN, USA. cherzog@usrds.org
Summary
Chronic kidney disease (CKD) significantly impacts patient outcomes, necessitating updated staging. Research explores cardiovascular disease prevention and treatment in CKD patients, including contrast-induced acute kidney injury (CI-AKI) and cardiac risk stratification.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Chronic kidney disease (CKD) is a significant comorbidity associated with adverse cardiovascular outcomes and increased mortality.
- Cardiovascular disease (CVD) is a leading cause of death in patients with CKD.
- Management of CVD in CKD patients presents unique challenges due to altered physiology and treatment complexities.
Purpose of the Study:
- To review current research on the interplay between CKD and cardiovascular disease.
- To highlight advancements in risk stratification, prevention, and treatment strategies for CVD in CKD populations.
- To discuss emerging trends in managing complications such as contrast-induced acute kidney injury (CI-AKI).
Main Methods:
- Systematic review of recent studies focusing on CKD and cardiovascular health.
- Analysis of clinical trials investigating CVD prevention and treatment in CKD patients.
- Evaluation of research on diagnostic imaging and risk stratification tools.
Main Results:
- CKD severity, particularly proteinuria, is a strong predictor of mortality, suggesting a need for revised staging.
- Echocardiography combined with cardiac biomarkers aids risk stratification in dialysis patients.
- Preventing CI-AKI remains a challenge, with ongoing research into effective strategies.
- Chest ultrasound shows promise for guiding fluid management in dialysis patients.
- Clinical trials are evaluating folic acid, statins, and aspirin for CVD prevention in CKD.
- Interventional and surgical treatments for ischemic and valvular heart disease in dialysis patients are under investigation, including allopurinol for ischemic heart disease.
Conclusions:
- CKD significantly influences cardiovascular outcomes, underscoring the need for integrated care.
- Novel approaches in risk assessment and therapeutic interventions are crucial for improving CVD management in CKD.
- Further research is essential to optimize prevention and treatment strategies for cardiovascular complications in this vulnerable population.
Related Concept Videos
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:18Chronic Kidney Disease IV: Nursing Management
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...